IPO - Check IPO Date, Price, Lot Size

Sudeep Pharma Ltd IPO

We are a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries. We have established a presence in both, domestic and international markets, including key regions such as the United States, South America, Europe, the Middle East, Africa, and Asia-Pacific. We operate three manufacturing facilities in Vadodara, Gujarat as of June 30, 2025. Further, pursuant to our acquisition of NSS as a Material Subsidiary with effect from May 22, 2025, we also have a manufacturing facility in Ireland. For details in relation to expenses incurred by us on research and development.

Sudeep Pharma Ltd IPO Details

Total Shares Offered

₹ 1,50,92,750

Offer to Public

1,34,90,726

Retail Max (Shares)

₹ 52,82,462

Pre Issue Promoters Holding

₹ 9,95,03,523

Exchange

BSE

Issue size

₹ 895 Cr

IPO Open Date

Nov 21, 2025

Close Date

Nov 25, 2025

Lot Size

Min Investment

₹ 14,075

Issue Type

Book Building

Listing Date

Nov 28, 2025

Sudeep Pharma Ltd IPO Dates

Nov 21, 2025

Opening date

Nov 25, 2025

Closing date

Nov 26, 2025

Basis of Allotment

Nov 27, 2025

Initiation of Refunds

Nov 27, 2025

Credit of Shares

Nov 28, 2025

Listing date

Details

Sector	Type
Sector	Pharmaceuticals - Indian - Bulk Drugs & Formln
Sub Sector	NA
Issue Type	Book Building

Subscription Status

*Values are in Lakhs

Investor Type	Subscription Times	Shares Offered*	Shares Bid*
QIB	85.23x	7546375	643188450
NII	116.72x	2263913	264240450
Retail	15.65x	5282462	82671250
Employee	0x	0	0
Total	65.6x	15092750	990100150

Investor Type

QIB

NII

Retail

Employee

Total

Subscription Times

85.23x

116.72x

15.65x

65.6x

7546375

2263913

5282462

15092750

643188450

264240450

82671250

990100150

Sudeep Pharma Ltd Financial Status

Income Statement

Particulars (In Rs. Crores)

Balance Sheet

Particulars (In Rs. Crores)

Particulars (in Rs. Crores)	FY23	FY22	FY21
Revenue from operations	135.52	137.46	95.60
EBITDA	141.64	142.61	100.43
PAT	95.75	98.08	67.17
Total Assets	315.86	233.74	235.34
Share Capital	11.98	1.41	1.41
Total Borrowings	162.19	96.56	120.02
Operating Activities (Net Cash)	101.87	103.23	72.00
Investing Activities (Net Cash)	-56.20	-14.75	-6.89
Financing Activities (Net Cash)	162.19	96.56	120.02
Net Cashflow	45.35	8.59	6.35

About Sudeep Pharma Ltd

Our Company was incorporated as `Sudeep Pharma Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated December 21, 1989, issued by the Registrar of Companies, Gujarat at Ahmedabad. Thereafter, our Company was converted into a public limited company and the name of our Company was accordingly changed to `Sudeep Pharma Limited' pursuant to fresh certificate of incorporation dated April 5, 1995, issued by the Assistant Registrar of Companies, Gujarat at Dadra & Nagar Haveli. Our Company was subsequently converted back to a private limited company under the Companies Act, 2013 vide a fresh certificate of incorporation dated October 1, 2014 issued by the Assistant Registrar of Companies, Gujarat at Ahmedabad, and the name of our Company was accordingly changed from `Sudeep Pharma Limited' to `Sudeep Pharma Private Limited'. Further, pursuant to the special resolution passed by our shareholders dated August 17, 2024 and the fresh certificate of incorporation dated October 21, 2024 issued by the Registrar of Companies, Central Processing Centre, our Company was converted into a public limited company and consequently, the name of our Company was changed to `Sudeep Pharma Limited'.

The global food ingredients market reflects distinct trends across regions, shaped by consumer preferences, regulatory environments, and industry advancements. The specialty food ingredients market is rapidly expanding, driven by growing consumer demand for healthier and more innovative food products. Advancements in distribution channels, personalized nutrition, and integration into functional foods contribute to the expansion of the global market for vitamins and minerals.

Peer Comparison:

No Listed Industry Peers

Sudeep Pharma Ltd Key Points

Strengths

Market leadership with a diversified product portfolio in a high barrier industry.

Distinguished global customer base with long-standing relationships with key customers.

Well-equipped and regulatory compliant Manufacturing Facilities.

Strong research and development capabilities.

Experienced Promoters and senior management team.

Risk

We generate a significant portion of our revenues from a limited number of customers and the loss of such customers or a decline in demand from such customers could adversely affect our business, results of operations, financial condition, and cash flows.

We generated 66.43%, 65.84%, 67.64% and 77.01% of our revenue from operations from our pharmaceutical, food and nutrition segment, in the three months ended June 30, 2025 and Fiscals 2025, 2024 and 2023, respectively. Any adverse developments affecting this segment may adversely affect our business, results of operations, financial condition, and cash flows.

Our Manufacturing Facilities are subject to periodic inspections and audits by regulatory authorities and customers and any manufacturing or quality control problems may subject us to regulatory action, damage our reputation and have an adverse effect on our business and results of operations.

Strategy

Expand into high-growth businesses.

Expand market reach through multiple growth initiatives.

Develop customized solutions and enter into strategic partnerships to drive growth.

Integrate recently acquired entities and continue evaluating inorganic growth opportunities.

Enhance manufacturing capabilities.

How To Apply for Sudeep Pharma Ltd IPO Online?

Step 1:

Step 2:

From the list of open IPOs, select the IPO you want to invest.

Step 3:

Go through the IPO details like lot size, price band, about the company, etc.

Step 4:

Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.

Step 5:

Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.

FAQs on IPO (Initial Public Offering)

What is the issue size of the Sudeep Pharma Ltd IPO?

Sudeep Pharma Ltd's IPO offers shares for up to 95 It begins on Nov 21, 2025 and ends on Nov 25, 2025.

What is the price of the Sudeep Pharma Ltd IPO?

The price of Sudeep Pharma Ltd IPO ranges between ₹563 to ₹593 per share.

What are the open and close dates for the Sudeep Pharma Ltd IPO?

The Sudeep Pharma Ltd IPO opens on Nov 21, 2025 and closes on Nov 25, 2025.

When will the Sudeep Pharma Ltd IPO be allotted?

The allotment for the Sudeep Pharma Ltd IPO will be finalised on Nov 26, 2025. The shares will be listed on BSE and NSE on Nov 28, 2025.

What is the minimum lot size required for Sudeep Pharma Ltd IPO?

The minimum lot size for Sudeep Pharma Ltd IPO is 25 shares, priced between ₹563 to ₹593 per share.

What is the GMP of Sudeep Pharma Ltd IPO?

The GMP (Grey Market Premium) of Sudeep Pharma Ltd IPO fluctuates based on market demand and sentiment.

How do you check the allotment status of Sudeep Pharma Ltd IPO?

To check the allotment status of Sudeep Pharma Ltd IPO, visit the registrar's website, select the IPO, enter your PAN Card number, Application Number, or DP Client ID, and click 'search.'

Where is the Sudeep Pharma Ltd IPO getting listed?

The Sudeep Pharma Ltd IPO is getting listed on the BSE and NSE. Bidding opens on Nov 21, 2025, and closes on Nov 25, 2025. The allotment is finalised on Nov 26, 2025.

How do you apply for the Sudeep Pharma Ltd IPO?

To apply for the Sudeep Pharma Ltd IPO, download the BlinkX app, complete KYC, select the IPO, enter bid details, and submit. Verify UPI payment for shares allotment.